PRESS RELEASE
7 February 2025

Webinar – Breakthroughs And Boundaries: IP Protection, Ethics In Biotech, And SPCs

H
HLK

Contributor

HLK is a global cooperation combining Haseltine Lake Kempner LLP and HL Kempner Partnerschaft mbB and provides a full suite of IP services advising across the entire IPR Lifespan™ in all technical and scientific disciplines. With offices in London, Bristol, Munich, Leeds, Glasgow, and Guangzhou (China), HLK provides IP services across the globe. HLK’s resources and expertise are exclusively dedicated to IP protection: safeguarding the inventions, creative designs, brand identities and other innovations of its clients. HLK advises on the strategy, identification, protection, opposition and appeal, exploitation and enforcement of IP rights, and defends its clients from allegations of infringement by focusing on acquiring competitive advantage for its clients. HLK is privileged to work with some of the most exciting and forward-looking businesses in the world which are at the forefront of innovation and product development in their various spheres.
Join us on Wednesday 12 March at 14:30-15:30 GMT | 15:30-16:30 CET for an insightful webinar addressing key topics in the pharmaceutical industry, where our experts will delve into:
United Kingdom

Host and speakers: Michael Ford, Partner and Isobel Finnie, Partner and David Hammond, Partner and Greg Ward, Partner

Join us on Wednesday 12 March at 14:30-15:30 GMT | 15:30-16:30 CET for an insightful webinar addressing key topics in the pharmaceutical industry, where our experts will delve into:

  • IP protection for AI driven innovation – Strategies for safeguarding AI-driven innovations in the pharmaceutical sector.
  • The ethics of patenting human-pig chimeras: The EPO's moral stand – Considering the European Patent Office's decision on the patentability of human-pig chimeras under Article 53(a) EPC in the recent case T1553/22.
  • SPCs: Coherence and combinations – Expert insights into the UK Court of Appeal's decision on Merck's SPC for cladribine in the post-Brexit landscape and the CJEU's rulings on SPCs for combination products.

This webinar will provide valuable perspectives on navigating legal and ethical challenges in pharma innovation.

Register now

Contributor

HLK is a global cooperation combining Haseltine Lake Kempner LLP and HL Kempner Partnerschaft mbB and provides a full suite of IP services advising across the entire IPR Lifespan™ in all technical and scientific disciplines. With offices in London, Bristol, Munich, Leeds, Glasgow, and Guangzhou (China), HLK provides IP services across the globe. HLK’s resources and expertise are exclusively dedicated to IP protection: safeguarding the inventions, creative designs, brand identities and other innovations of its clients. HLK advises on the strategy, identification, protection, opposition and appeal, exploitation and enforcement of IP rights, and defends its clients from allegations of infringement by focusing on acquiring competitive advantage for its clients. HLK is privileged to work with some of the most exciting and forward-looking businesses in the world which are at the forefront of innovation and product development in their various spheres.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More